XORTX Therapeutics (XRTX) Capital Leases (2023 - 2026)
XORTX Therapeutics' (XRTX) quarterly Capital Leases came in at $15056.0 in Q1 2026, down 3.87% YoY from $15662.0 in Q1 2025, and down 59.62% on a QoQ basis from $37287.0 in Q4 2025.
XORTX Therapeutics (XRTX) Capital Leases (2023 - 2026) Analysis & Trends
XORTX Therapeutics (XRTX) has 4 years of Capital Leases data on file, last reported at $15056.0 in Q1 2026.
- Quarterly Capital Leases fell 3.87% year-over-year to $15056.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $15056.0 (down 3.87% YoY) and the FY2025 annual result came in at $37287.0, down 3.86% from the prior year.
- Capital Leases declined to $15056.0 in Q1 2026, from $37287.0 in the prior quarter.
- In the past five years, Capital Leases ranged from a high of $83706.0 in Q2 2024 to a low of $11510.0 in Q4 2023.
- A 4-year average of $44782.3 and a median of $38785.0 in 2024 frame the typical range for Capital Leases.
- Annual changes were most pronounced in 2024 — Capital Leases soared 236.97% — and 2026, when it fell 3.87%.
- Tracing XRTX's Capital Leases over 4 years: stood at $11510.0 in 2023, then soared by 236.97% to $38785.0 in 2024, then slipped by 3.86% to $37287.0 in 2025, then plunged by 59.62% to $15056.0 in 2026.
- The last three Capital Leases figures came in at $15056.0 (Q1 2026), $37287.0 (Q4 2025), and $59094.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.69 Bn | 131.84 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.54 Bn | 78.54 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.27 Bn | 60.09 Bn | 1.37 Bn |
| 4 | Moderna | 59.41 Bn | 54.27 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.12 Bn | 37.02 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.80 Bn | 28.49 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.07 Bn | 9.68 Bn | 668.28 Mn |
| 8 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.28 Bn | 26.44 Bn | - |
| 10 | XORTX Therapeutics | 2.84 Mn | 2.84 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15,056.00 |
| Dec 31, 2025 | 37,287.00 |
| Sep 30, 2025 | 59,094.00 |
| Jun 30, 2025 | 80,473.00 |
| Mar 31, 2025 | 15,662.00 |
| Dec 31, 2024 | 38,785.00 |
| Sep 30, 2024 | 61,468.00 |
| Jun 30, 2024 | 83,706.00 |
| Dec 31, 2023 | 11,510.00 |